Fesoterodine for the treatment of overactive bladder -: A cost-effectiveness case study of Sweden

被引：0
|
作者：
Prutz, C. [1 ]
Snedecor, S. [4 ]
Botteman, M. [4 ]
Trocio, J. [2 ]
Weinstein, D. [3 ]
机构：
[1] Pfizer AB, Stockholm, Sweden
[2] Pfizer Inc, New York, NY USA
[3] Pfizer France, Paris, France
[4] Pharmerit N Amer, Bethesda, MD USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70951-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF TREATING OVERACTIVE BLADDER WITH MIRABEGRON VERSUS ANTIMUSCARINICS IN MEXICO
    Ng, D. B.
    Parise, H.
    Dea, K.
    Espinosa, R.
    Anaya, P.
    Gooch, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S266 - S267
  • [42] Cost-effectiveness of overactive bladder treatments: from the US payer perspective
    Murray, Brian
    Hessami, Sam H.
    Gultyaev, Dmitry
    Lister, Johanna
    Dmochowski, Roger
    Gillard, Kristin Khalaf
    Stanisic, Sanja
    Tung, Amy
    Boer, Robert
    Kaplan, Steven
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 61 - 72
  • [43] New Perspectives of Treatment With Fesoterodine Fumarate in Patients With Overactive Bladder
    Garcia-Baquero, R.
    Madurga, B.
    Garcia, M. V.
    Fernandez, M. A.
    Rosety, J. M.
    Alvarez-Ossorio, J. L.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (02): : 83 - 91
  • [44] Pharmacokinetic profile of fesoterodine, a novel antimuscarinic treatment for overactive bladder
    Malhotra, Bimal
    Wood, Nolan
    Guan, Zhonghong
    Gandelman, Kuan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 999 - 1000
  • [45] AN ECONOMIC EVALUATION OF FESOTERODINE IN THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN KOREA
    Jo, C.
    Lee, S. J.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A200 - A200
  • [46] Fesoterodine, an advanced antimuscarinic for the treatment of overactive bladder: A safety update
    Cole, P
    [J]. DRUGS OF THE FUTURE, 2004, 29 (07) : 715 - 720
  • [47] Understanding Dose Titration: Overactive Bladder Treatment With Fesoterodine as an Example
    Michel, Martin C.
    Staskin, David
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (01) : 8 - 13
  • [48] NEUROSTIMULATION TREATMENT FOR OVERACTIVE BLADDER: AN EVALUATION OF COST EFFECTIVENESS DATA
    MacDiarmid, Scott
    Martinson, Melissa
    Black, Edward
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E478 - E478
  • [49] Optimizing quality of care and cost effectiveness in the treatment of overactive bladder
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (02): : S43 - S45
  • [50] NEUROSTIMULATION TREATMENT FOR OVERACTIVE BLADDER: AN EVALUATION OF COST EFFECTIVENESS DATA
    MacDiarmid, Scott
    Martinson, Melissa
    Black, Edward
    [J]. NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 112 - 112
12345